Back to Search
Start Over
First-in-human phase 1 trial of the safety and immunogenicity of a recombinant adenovirus serotype 5 HVR48 (rAd5HVR48) HIV-1 vaccine
- Source :
- Retrovirology, Vol 9, Iss Suppl 2, p O52 (2012)
- Publication Year :
- 2012
- Publisher :
- BMC, 2012.
- Subjects :
- Immunologic diseases. Allergy
RC581-607
Subjects
Details
- Language :
- English
- ISSN :
- 17424690
- Volume :
- 9
- Issue :
- Suppl 2
- Database :
- Directory of Open Access Journals
- Journal :
- Retrovirology
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.3db2bdf72d04b718ea33165c8cf34a1
- Document Type :
- article
- Full Text :
- https://doi.org/10.1186/1742-4690-9-S2-O52